Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

56 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
CREBBP histone acetyltransferase domain mutations predict response to mTOR inhibition in relapsed/refractory follicular lymphoma.
Kumar EA, Korfi K, Bewicke-Copley F, Close K, Heward J, Witzig T, Leukam M, Ansell S, Scott J, Clear A, Efeyan A, Green M, Siebert R, Peck B, Calaminici M, Wang J, Smith S, Novak A, Fitzgibbon J, Okosun J. Kumar EA, et al. Among authors: okosun j. Br J Haematol. 2024 Nov;205(5):1804-1809. doi: 10.1111/bjh.19671. Epub 2024 Aug 26. Br J Haematol. 2024. PMID: 39188028
Prospects for liquid biopsy approaches in lymphomas.
Jamal E, Poynton E, Elbogdady M, Shamaa S, Okosun J. Jamal E, et al. Among authors: okosun j. Leuk Lymphoma. 2024 Dec;65(13):1923-1933. doi: 10.1080/10428194.2024.2389210. Epub 2024 Aug 10. Leuk Lymphoma. 2024. PMID: 39126310 Free PMC article. Review.
Investigator choice of standard therapy versus sequential novel therapy arms in the treatment of relapsed follicular lymphoma (REFRACT): study protocol for a multi-centre, open-label, randomised, phase II platform trial.
McIlroy G, Lax S, Gaskell C, Jackson A, Rhodes M, Seale T, Fox S, Hopkins L, Okosun J, Barrington SF, Ringshausen I, Ramsay AG, Calaminici M, Linton K, Bishton M. McIlroy G, et al. Among authors: okosun j. BMC Cancer. 2024 Mar 25;24(1):370. doi: 10.1186/s12885-024-12112-0. BMC Cancer. 2024. PMID: 38528445 Free PMC article.
Targeting lysine demethylase 5 (KDM5) in mantle cell lymphoma.
Xu D, Bewicke-Copley F, Close K, Okosun J, Gale RP, Apperley J, Weinstock DM, Wendel HG, Fitzgibbon J. Xu D, et al. Among authors: okosun j. Blood Cancer J. 2024 Feb 13;14(1):29. doi: 10.1038/s41408-024-00999-8. Blood Cancer J. 2024. PMID: 38351059 Free PMC article. No abstract available.
DLBCL arising from indolent lymphomas: How are they different?
Parry EM, Roulland S, Okosun J. Parry EM, et al. Among authors: okosun j. Semin Hematol. 2023 Nov;60(5):277-284. doi: 10.1053/j.seminhematol.2023.11.002. Epub 2023 Nov 23. Semin Hematol. 2023. PMID: 38072721 Free article. Review.
Impact of MYC and BCL2 double expression on outcomes in primary CNS lymphoma: a UK multicenter analysis.
Poynton E, Chernucha E, Day J, Prodger C, Hopkins D, Rakesh P, O'Neill T, Thakrar N, Akarca A, Jamal E, Ali A, Kirkwood AA, Pomplun S, Marafioti T, Calaminici M, Greaves P, Chaganti S, McKay P, Smith J, Eyre TA, Martinez-Calle N, Cwynarski K, Fox CP, Okosun J. Poynton E, et al. Among authors: okosun j. Blood Adv. 2024 Apr 9;8(7):1772-1775. doi: 10.1182/bloodadvances.2023011426. Blood Adv. 2024. PMID: 38039509 Free PMC article. No abstract available.
Personalised therapy in follicular lymphoma - is the dial turning?
Linton KM, Specht L, Pavlovsky A, Thompson CA, Kimby E, de Jong D, Nastoupil LJ, Cottereau AS, Casulo C, Sarkozy C, Okosun J. Linton KM, et al. Among authors: okosun j. Hematol Oncol. 2024 Nov;42(6):e3205. doi: 10.1002/hon.3205. Epub 2023 Jul 22. Hematol Oncol. 2024. PMID: 37482955 Free PMC article. Review.
56 results